• Explore /
  • Poster
  • / Final results of the ACTS-CC 02 trial: A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/leucovorin as adjuvant chemotherapy for high-risk stage III colon cancer.

Final results of the ACTS-CC 02 trial: A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/leucovorin as adjuvant chemotherapy for high-risk stage III colon cancer.

Abstract Video & Slides Poster

Authors

null

Naohiro Tomita

Division of Lower GI Surgery, Department of Surgery, Hyogo College of Medicine, Hyogo, Japan

Naohiro Tomita , Shin Sasaki , Tetsuya Kusumoto , Jun Watanabe , Yoshiyuki Sakamoto , Kazuhiro Yoshida , Atsuyuki Maeda , Jin Teshima , Mitsuru Yokota , Chihiro Tanaka , Junichiro Yamauchi , Hiroyuki Uetake , Michio Itabashi , Keiichi Takahashi , Hideo Baba , Kenjiro Kotake , Narikazu Boku , Keisuke Aiba , Satoshi Morita , Kenichi Sugihara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Colorectal Cancer

Track

Colorectal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

JapicCTI-101073

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 59)

DOI

10.1200/JCO.2021.39.3_suppl.59

Abstract #

59

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Takuya Miura

Poster

2015 ASCO Annual Meeting

S-1 as adjuvant chemotherapy for stage III colon cancer: Updated outcomes of ACTS-CC trial.

S-1 as adjuvant chemotherapy for stage III colon cancer: Updated outcomes of ACTS-CC trial.

First Author: Yusuke Kinugasa

First Author: Tetsuya Hamaguchi

First Author: Julien Taïeb